ABNORMAL HEMOGLOBIN SYNTHESIS--MECHANISM & DETECTION
ABNORMAL HEMOGLOBIN SYNTHESIS--MECHANISM & DETECTION
批准号:
3151021
负责人:
YUET Wai KAN
金额:
$27.22万
依托单位国家:
美国
项目类别:
财政年份:
1976
资助国家:
美国
项目状态:
已结题
起止时间:
1976-08-01 至 1986-07-31
关键词:
African American affinity chromatography biological polymorphism cell free system chemical structure function diagnosis quality /standard embryo /fetus evolution gene mutation genetic disorder diagnosis genetic manipulation hemoprotein biosynthesis human subject human tissue messenger RNA molecular cloning molecular pathology nucleic acid sequence orphan disease /drug prenatal diagnosis sickle cell anemia structural genes thalassemia
中文摘要
我们计划开发镰状细胞性贫血的产前诊断方法,并
地中海贫血,研究人类群体中镰刀基因的进化,并
探讨糖尿病患者珠蛋白产生异常的分子机制
地中海贫血。在产前诊断中,我们将寻找DNA的多态性
可用于镰刀基因与水稻的连锁分析的序列
不同类型的β地中海贫血基因。我们将设计方法来分析
镰刀状突变中的核苷酸直接改变。我们还将使用
用分子克隆技术研究沙门氏菌核苷酸序列的差异
S和C基因,确定其进化谱系。在贝塔地中海贫血患者中,我们
计划寻找不同类型的无义突变作为贝塔病毒的原因
地中海贫血。我们将首先利用抑制子tRNA检测无稽之谈
突变并通过克隆基因和序列来确定确切的突变
分析。在阿尔法地中海贫血中,我们将研究其产生机制
通过DNA分子克隆的非缺失型阿尔法地中海贫血,
通过序列分析确定它们的结构,并分析
这些基因在体外系统中的功能。
英文摘要
We plan to develop methods for the prenatal diagnosis of sickle cell anemia and
thalassemia, to study evolution of the sickle gene in human populations, and to
investigate the molecular mechanism underlying abnormal globin production in
thalassemia. In prenatal diagnosis, we will search for polymorphism in DNA
sequence which can be used for linkage analysis of the sickle gene and the
different types of beta thalassemia genes. We will devise methods to analyze
directly the nucleotide change in the sickle mutation. We will also use
molecular cloning to study the divergence between the nucleotide sequence of the
S and C gene to determine their evolutionary lineage. In beta thalassemia, we
plan to search for different types of nonsense mutations as the cause for beta
thalassemia. We will first utilize the suppressor tRNA assay to detect nonsense
mutation and determine the exact mutations by cloning the gene and sequence
analysis. In alpha thalassemia, we will study the mechanism of production of
the non-deletion type of alpha thalassemia by molecular cloning of the DNA,
determination of their structures by sequences analysis, and assaying the
function of these genes in in vitro systems.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Application of DNA polymorphisms for prenatal diagnosis of beta thalassemia in Chinese.
DNA多态性在中国人β地中海贫血产前诊断中的应用
DOI:
10.1002/ajh.2830250407
发表时间:
1987
期刊:
American journal of hematology
影响因子:
12.8
作者:
[Chan,V, Chan,TK, Ghosh,A, Wong,LC, Ma,HK, Kan,YW, Todd,D]
通讯作者:
Todd,D
Ferrara beta 0 thalassaemia caused by the beta 39 nonsense mutation.
Ferrara β 0 地中海贫血是由 β 39 无义突变引起的。
DOI:
10.1038/307076a0
发表时间:
1984
期刊:
Nature
影响因子:
64.8
作者:
[Pirastu,M, delSenno,L, Conconi,F, Vullo,C, Kan,YW]
通讯作者:
Kan,YW
Prenatal diagnosis by DNA analysis.
通过 DNA 分析进行产前诊断。
DOI:
--
发表时间:
1982
期刊:
Birth defects original article series
影响因子:
--
作者:
[Kan,YW, Chang,JC, Dozy,AM]
通讯作者:
Dozy,AM
Hemolytic disease of the newborn caused by a new deletion of the entire beta-globin cluster.
由整个β-珠蛋白簇的新缺失引起的新生儿溶血病。
DOI:
10.1172/jci111008
发表时间:
1983
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
[Pirastu,M, Kan,YW, Lin,CC, Baine,RM, Holbrook,CT]
通讯作者:
Holbrook,CT
Initiation codon mutation as a cause of alpha thalassemia.
起始密码子突变是α地中海贫血的原因。
DOI:
--
发表时间:
1984
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Pirastu,M, Saglio,G, Chang,JC, Cao,A, Kan,YW]
通讯作者:
Kan,YW
共 19 条
Reprogramming iPS Cells with Exogenous and Endogenous Transcription Factor Genes
-
批准号:8917047
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2015
-
负责人:YUET Wai KAN
-
依托单位:
Reprogramming iPS Cells with Exogenous and Endogenous Transcription Factor Genes
-
批准号:8710193
-
项目类别:
-
资助金额:$38.12万
-
财政年份:2014
-
负责人:YUET Wai KAN
-
依托单位:
Development of iPS Cells for Treatment of Hemoglobinopathies
-
批准号:8710192
-
项目类别:
-
资助金额:$129.97万
-
财政年份:2011
-
负责人:YUET Wai KAN
-
依托单位:
Development of iPS Cells for Treatment of Hemoglobinopathies
-
批准号:8332252
-
项目类别:
-
资助金额:$130.63万
-
财政年份:2011
-
负责人:YUET Wai KAN
-
依托单位:
Development of iPS Cells for Treatment of Hemoglobinopathies
-
批准号:8150802
-
项目类别:
-
资助金额:$133.4万
-
财政年份:2011
-
负责人:YUET Wai KAN
-
依托单位:
Development of iPS Cells for Treatment of Hemoglobinopathies
-
批准号:8532884
-
项目类别:
-
资助金额:$125.56万
-
财政年份:2011
-
负责人:YUET Wai KAN
-
依托单位:
Development of iPS Cells for Treatment of Hemoglobinopathies
-
批准号:8917036
-
项目类别:
-
资助金额:$129.14万
-
财政年份:2011
-
负责人:YUET Wai KAN
-
依托单位:
FETAL MONKEY MODEL FOR GENE THERAPY FOR SICKLE CELL DISEASE
-
批准号:7715557
-
项目类别:
-
资助金额:$2.71万
-
财政年份:2008
-
负责人:YUET Wai KAN
-
依托单位:
FETAL MONKEY MODEL FOR GENE THERAPY FOR SICKLE CELL DISEASE
-
批准号:7562145
-
项目类别:
-
资助金额:$2.46万
-
财政年份:2007
-
负责人:YUET Wai KAN
-
依托单位:
FETAL MONKEY MODEL FOR GENE THERAPY FOR SICKLE CELL DISEASE
-
批准号:7349628
-
项目类别:
-
资助金额:$2.48万
-
财政年份:2006
-
负责人:YUET Wai KAN
-
依托单位:
FETAL MONKEY MODEL FOR GENE THERAPY FOR SICKLE CELL DISEASE
-
批准号:7165426
-
项目类别:
-
资助金额:$2.77万
-
财政年份:2005
-
负责人:YUET Wai KAN
-
依托单位:
AAV Mediated Angiogenic Therapy for Coronary Disease
-
批准号:6575928
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2002
-
负责人:YUET Wai KAN
-
依托单位:
AAV vectors expressing angiogenic factors for CHD
-
批准号:6664069
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2002
-
负责人:YUET Wai KAN
-
依托单位:
AAV Mediated Angiogenic Therapy for Coronary Disease
-
批准号:6979799
-
项目类别:
-
资助金额:$29.59万
-
财政年份:2002
-
负责人:YUET Wai KAN
-
依托单位:
AAV Mediated Angiogenic Therapy for Coronary Disease
-
批准号:6818775
-
项目类别:
-
资助金额:$30.3万
-
财政年份:2002
-
负责人:YUET Wai KAN
-
依托单位:
SICKLE CELL ANEMIA MOUSE MODEL
-
批准号:6650008
-
项目类别:
-
资助金额:$13.59万
-
财政年份:2002
-
负责人:YUET Wai KAN
-
依托单位:
AAV Mediated Angiogenic Therapy for Coronary Disease
-
批准号:6688239
-
项目类别:
-
资助金额:$30.3万
-
财政年份:2002
-
负责人:YUET Wai KAN
-
依托单位:
AAV vectors expressing angiogenic factors for CHD
-
批准号:6501564
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2001
-
负责人:YUET Wai KAN
-
依托单位:
SICKLE CELL ANEMIA MOUSE MODEL
-
批准号:6504132
-
项目类别:
-
资助金额:$13.59万
-
财政年份:2001
-
负责人:YUET Wai KAN
-
依托单位:
AAV vectors expressing angiogenic factors for CHD
-
批准号:6365587
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2000
-
负责人:YUET Wai KAN
-
依托单位:
海外基金